In patients with early-stage HER2-positive breast cancer in the DESTINY-Breast 05 and the DESTINY-Breast 11 trials, ...

"Whatever remains of my life, I'm going to live it the way that I want," Melissa Fouts says ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Camrelizumab and famitinib are projected to achieve global annual sales of $463 million and $108 million by 2031.

Consolidative radiotherapy (RT) can improve outcomes in patients with diffuse large B-cell lymphoma (DLBCL), according to a ...

New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...

A University of Alberta research team has uncovered a new role for a genetic mutation previously known to be linked to ...

River Brennan was 11 when he felt lumps on his neck a few weeks after his family's summer vacation in 2024. He was diagnosed with T-cell lymphoblastic lymphoma and had to miss most of his sixth-grade ...

Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain." ...